Purpose: Due to the low rate of parent acceptance of vaccines, this study was conducted to evaluate post-vaccination adverse events among elementary school students. Methods: This survey took place in the Manggala Subdistrict of Makassar City. The study was conducted from September to October 2022 by distributing a paper-based questionnaire regarding the COVID-19 vaccines. Results: Of 129 respondents, the age range was 7-12 years. Sixty-five percent of respondents received the first vaccine shot in January or February, with a 4-week interval of the second dose among 46.5% of children. The vaccine administered was CoronaVac from Sinovac. The most common adverse events were injection pain (45-48%) and fever (15-17%). The other side effects were itching, swelling, fever, and shortness of breath. Around 17-18 % of respondents did not have any adverse reactions. There is no increase in the risk for younger children (years 1-3) compared with older children (years 4-6). Conclusion: The children reported only mild adverse events such as injection pain, weakness, and fever. The CoronaVac has minimal side effects among elementary school children.
No takes yet. Share an insight, caveat, or question.
Yusuf et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: